Carmel Diagnostics, developed and validated novel non-invasive assays that are based on the measurement of Oxidative Stress in body or biological fluids using a patented process known as thermochemiluminescence (TCL). TCL and the TCL Analyzer are game changers, being the first and only tool available to make OS a useful biomarker. Carmel focuses on its lead application, a non-invasive method for assessing embryo viability for in vitro fertilization (IVF).